Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Clinical Trial ID NCT01055314

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
2	NK cell-based immunotherapies in Pediatric Oncology.	J Pediatr Hematol Oncol	2015	0.85
3	Camptothecin-based regimens for treatment of ewing sarcoma: past studies and future directions.	Sarcoma	2011	0.83
4	Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?	Clin Sarcoma Res	2015	0.79
5	Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives.	Oncol Rev	2013	0.79
6	Immunotherapy in pediatric malignancies: current status and future perspectives.	Future Oncol	2014	0.78
7	18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.	Pediatr Blood Cancer	2012	0.78
8	Vincristine sulfate liposomal injection for acute lymphoblastic leukemia.	Int J Nanomedicine	2013	0.78
9	Targeting angiogenesis in childhood sarcomas.	Sarcoma	2010	0.77
10	Metastatic malignant ectomesenchymoma initially presenting as a pelvic mass: report of a case and review of literature.	Case Rep Pediatr	2014	0.77